Clinical Trials | March 23, 2024
AstraZeneca’s FLAURA2 Phase III trial showed favourable trend in EGFR-mutated advanced lung cancer
Combination shows consistent benefit across prespecified post-progression outcomes
Combination shows consistent benefit across prespecified post-progression outcomes
Operations of Line II was stopped due to a fire incident earlier
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
A five-day inspection was concluded successfully with no critical and no major observations raised
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager
More than 10,000 scientific publications containing EUDRAGIT
Sen spent a decade with Biocon and held various key roles,
Subscribe To Our Newsletter & Stay Updated
